Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute...

Area of Science:

• Hematology
• Immunophenotyping
• Pediatric Oncology

Background:

• Acute leukemias exhibit diverse lineage-specific antigens, including CD34, a common hematopoietic progenitor cell antigen.
• Normal hematopoietic stem cell models involve CD34+ Thy-1low Lin-, CD34+ CD38-, and CD34+ HLA-DR- phenotypes.
• Understanding antigen expression is crucial for differentiating leukemic cells from normal stem cells.

Purpose of the Study:

• To analyze the expression patterns of CD34, Thy-1, CD38, HLA-DR, and lineage-specific antigens in pediatric B-cell precursor acute lymphoblastic leukemia (ALL).
• To evaluate the utility of different phenotypes (CD34+ Thy-1low, CD34+ CD38-, CD34+ HLA-DR-) in distinguishing leukemic cells from normal hematopoietic stem cells.

Main Methods:

• Immunophenotyping was performed on 49 pediatric B-cell precursor ALL cases (36 at diagnosis, 13 at relapse).
• Expression levels of CD34, Thy-1, CD38, HLA-DR, and lineage-specific antigens were analyzed.
• Statistical analysis was used to correlate antigen expression patterns.

Main Results:

• CD34 expression was detected in 67% of pediatric B-cell precursor ALL cases.
• CD34+ expression significantly correlated with Thy-1low expression and myeloid antigen expression.
• The CD34+ Thy-1low phenotype was observed in 65% of cases, while CD34+ CD38- or CD34+ HLA-DR- phenotypes were rare.
• Heterogeneous CD34 and Thy-1 expression occurred in some cases, but CD38 expression was consistently homogeneous.

Conclusions:

• The CD34+ Thy-1low phenotype is common in pediatric B-cell precursor ALL but less effective for distinguishing leukemic cells from normal hematopoietic stem cells.
• CD34+ CD38- and CD34+ HLA-DR- phenotypes appear more valuable for differentiating normal hematopoietic stem cells from leukemic cells in this patient population.